The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 27, 2012
Filed:
May. 25, 2011
Christopher I. Bayly, Beaconsfield, CA;
Cameron Black, Baie d'Urfe, CA;
Serge Leger, Notre-Dame-de I'lle-Perrot, CA;
Chun Sing LI, Dollard-des-Ormeaux, CA;
Dan Mckay, Ottawa, CA;
Christophe Mellon, L'lle-Bizard, CA;
Jacques Yves Gauthier, Laval, CA;
Vouy-linh Truong, Pierrefonds, CA;
Cheuk Lau, L'lle Bizard, CA;
Michel Therien, Laval, CA;
Michael J. Green, Half Moon Bay, CA (US);
Bernard L. Hirschbein, San Francisco, CA (US);
James William Janc, Burlingame, CA (US);
James T. Palmer, Corte Madera, CA (US);
Chitra Baskaran, Foster City, CA (US);
Christopher I. Bayly, Beaconsfield, CA;
Cameron Black, Baie d'Urfe, CA;
Serge Leger, Notre-Dame-de I'lle-Perrot, CA;
Chun Sing Li, Dollard-des-Ormeaux, CA;
Dan McKay, Ottawa, CA;
Christophe Mellon, L'lle-Bizard, CA;
Jacques Yves Gauthier, Laval, CA;
Vouy-Linh Truong, Pierrefonds, CA;
Cheuk Lau, L'lle Bizard, CA;
Michel Therien, Laval, CA;
Michael J. Green, Half Moon Bay, CA (US);
Bernard L. Hirschbein, San Francisco, CA (US);
James William Janc, Burlingame, CA (US);
James T. Palmer, Corte Madera, CA (US);
Chitra Baskaran, Foster City, CA (US);
Merck, Sharp & Dohme Corp., Rahway, NJ (US);
Axys Pharmaceuticals, Inc., South San Francisco, CA (US);
Abstract
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.